Laxmi Dental Q4FY26 Revenue Surges 21.9% YoY to ₹74 Crore
Laxmi Dental reported its highest-ever quarterly revenue of ₹74 crore for Q4 FY26, up 21.9% YoY. Full-year revenue grew 16.2% to ₹278 crore. EBITDA margin was 18.3% for the quarter. Management highlighted strong performance in Dental Laboratory and Aligner Solutions businesses.
The announcement pertains to the company's financial results, which are a key factor for investors and directly impact the company's valuation and stock performance.
The company reported record quarterly revenue and significant year-on-year growth in revenue and profits, indicating a strong financial performance.
Laxmi Dental Limited announced its audited consolidated financial results for the quarter and financial year ended March 31, 2026. The company reported its highest-ever quarterly revenue of ₹739.5 million (₹73.95 crore) for Q4 FY26, marking a significant 21.9% year-on-year growth. EBITDA for the quarter stood at ₹135.0 million (₹13.50 crore), an increase of 41.8% YoY, with an EBITDA margin of 18.3%. Profit Before Tax (PBT) after exceptional items was ₹111.4 million (₹11.14 crore), up 85.3% YoY. For the full financial year FY26, revenue grew by 16.2% YoY to ₹2,778.6 million (₹277.86 crore), while PBT saw a marginal decline of 9.1% YoY to ₹289.3 million (₹28.93 crore), largely due to a non-comparable higher base in FY25 from a property sale gain.
Key performance highlights for Q4 FY26 include strong revenue growth driven by the Dental Laboratory business, which reported a 27% YoY increase, and a healthy performance in the Aligner Solutions business. The company's gross profit margins were 70.5%, with the core dental business excluding scanner sales maintaining ~76.0%. Scanner sales, though low margin, are considered strategic enablers for future growth. The company noted a 74 bps impact on EBITDA in the quarter due to higher US tariffs.
For FY26, the company faced multiple one-off impacts on margins, including a 72 bps US Tariff impact, a one-time expense of ₹57.8 million (₹5.78 crore) due to changes in the labour code, and higher ESOP expenses. The management expressed satisfaction with the strong quarterly exit and continuous efforts towards digitalization, with digital penetration in the Indian Dental business reaching approximately 80%.
What to do with a filing like this
Laxmi Dental Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Laxmi Dental Limited. Read the original for the full detail.